Last updated on August 2018

GRAVITAS-301: A Study of Itacitinib or Placebo in Combination With Corticosteroids for Treatment of Acute Graft-Versus-Host Disease

Brief description of study

The purpose of this study is to evaluate itacitinib or placebo in combination with corticosteroids as first-line treatment of participants with Grade II to IV acute graft-versus-host disease (aGVHD).

Clinical Study Identifier: NCT03139604

Contact Investigators or Research Sites near you

Start Over

Study Coordinator

Jessa Ziekenhuis
Hasselt, Belgium
  Connect »